New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection

Oncotarget

Volumn 7, Issue 10, 2016, Pages 10990-11001

  Wiehr, Stefan ^a   Warnke, Philipp ^a,e   Rolle, Anna Maria ^a   Schütz, Monika ^a   Oberhettinger, Philipp ^a   Kohlhofer, Ursula ^b   Quintanilla Martinez, Leticia ^b   Maurer, Andreas ^a   Thornton, Christopher ^c   Boschetti, Frederic ^d   Reischl, Gerald ^a   Autenrieth, Ingo B ^a   Pichler, Bernd J ^a   Autenrieth, Stella E ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d UNIVERSITÉ DE BOURGOGNE   (France)

^e ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

64Cu; Antibody; Bacteria; In vivo imaging; PET MR

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OUTER MEMBRANE PROTEIN; POLYCLONAL ANTIBODY; PROTEIN YADA; TRACER; UNCLASSIFIED DRUG; 1-(1,3-CARBOXYPROPYL)-4,7-CARBOXYMETHYL-1,4,7-TRIAZACYCLONONANE; ACETIC ACID DERIVATIVE; ADHESIN; BACTERIUM ANTIBODY; COPPER; RADIOPHARMACEUTICAL AGENT; SINGLE HETEROCYCLIC RINGS; YADA PROTEIN, YERSINIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HOST PATHOGEN INTERACTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOLOGICAL BLOCKING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; YERSINIA INFECTION; ANIMAL; C57BL MOUSE; DIAGNOSTIC IMAGING; IMMUNOLOGY; PROCEDURES; YERSINIA ENTEROCOLITICA;

ACETATES; ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; COPPER RADIOISOTOPES; FEMALE; HETEROCYCLIC COMPOUNDS, 1-RING; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 84961990467     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7770     Document Type: Article

References (46)

1. Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH and Signore A. The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol. 2013; 2013:623036.
2. Petruzzi N, Shanthly N and Thakur M. Recent trends in soft-tissue infection imaging. Semin Nucl Med. 2009; 39:115-123.
3. Coombes JL and Robey EA. Dynamic imaging of hostpathogen interactions in vivo. Nat Rev Immunol. 2010; 10:353-364.
4. Glaudemans AW, Galli F, Pacilio M and Signore A. Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater. 2013; 25:61-77.
5. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J and Signore A. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013; 54:647-658.
6. del Rosal T, Goycochea WA, Mendez-Echevarria A, Garcia-Fernandez de Villalta M, Baquero-Artigao F, Coronado M, Marin MD and Albajara L. (1)(8)F-FDG PET/CT in the diagnosis of occult bacterial infections in children. Eur J Pediatr. 2013; 172:1111-1115.
7. Glaudemans AW, Quintero AM and Signore A. PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? Eur J Nucl Med Mol Imaging. 2012; 39:745-749.
8. Schindler MK, Schutz MS, Muhlenkamp MC, Rooijakkers SH, Hallstrom T, Zipfel PF and Autenrieth IB. Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products. J Immunol. 2012; 189:4900-4908.
9. Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev. 1997; 10:257-276.
10. Autenrieth IB, Beer M, Bohn E, Kaufmann SH and Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun. 1994; 62:2590-2599.
11. Pasquevich KA, Bieber K, Gunter M, Grauer M, Potz O, Schleicher U, Biedermann T, Beer-Hammer S, Buhring HJ, Rammensee HG, Zender L, Autenrieth IB, Lengerke C and Autenrieth SE. Innate immune system favors emergency monopoiesis at the expense of DC-differentiation to control systemic bacterial infection in mice. Eur J Immunol. 2015; 45:2821-2833.
12. Di Genaro MS, Waidmann M, Kramer U, Hitziger N, Bohn E and Autenrieth IB. Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokinedeficient mice: implications for the development of novel live carrier vaccines. Infect Immun. 2003; 71:1804-1812.
13. Heesemann J, Gaede K and Autenrieth IB. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS. 1993; 101:417-429.
14. Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008; 15:1095-1105.
15. Becker W and Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis. 2001; 1:326-333.
16. Bates DW, Sands K, Miller E, Lanken PN, Hibberd PL, Graman PS, Schwartz JS, Kahn K, Snydman DR, Parsonnet J, Moore R, Black E, Johnson BL, Jha A and Platt R. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis. 1997; 176:1538-1551.
17. Weinstein EA, Ordonez AA, DeMarco VP, Murawski AM, Pokkali S, MacDonald EM, Klunk M, Mease RC, Pomper MG and Jain SK. Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med. 2014; 6:259ra146.
18. Bunschoten A, Welling MM, Termaat MF, Sathekge M and van Leeuwen FW. Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem. 2013; 24:1971-1989.
19. Dorward DA, Lucas CD, Rossi AG, Haslett C and Dhaliwal K. Imaging inflammation: molecular strategies to visualize key components of the inflammatory cascade, from initiation to resolution. Pharmacology & therapeutics. 2012; 135:182-199.
20. Glaudemans AW and Signore A. FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging. 2010; 37:1986-1991.
21. Autenrieth SE, Warnke P, Wabnitz GH, Lucero Estrada C, Pasquevich KA, Drechsler D, Gunter M, Hochweller K, Novakovic A, Beer-Hammer S, Samstag Y, Hammerling GJ, Garbi N and Autenrieth IB. Depletion of dendritic cells enhances innate anti-bacterial host defense through modulation of phagocyte homeostasis. PLoS Pathog. 2012; 8:e1002552.
22. Rolle AM, Soboslay PT, Reischl G, Hoffmann WH, Pichler BJ and Wiehr S. Evaluation of the Metabolic Activity of Echinococcus multilocularis in Rodents Using Positron Emission Tomography Tracers. Mol Imaging Biol. 2015.
23. Chacko TK, Zhuang H, Nakhoda KZ, Moussavian B and Alavi A. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun. 2003; 24:615-624.
24. Culverwell AD, Scarsbrook AF and Chowdhury FU. False-positive uptake on 2-[(1)(8)F]-fluoro-2-deoxy-Dglucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging. Clin Radiol. 2011; 66:366-382.
25. Jain SK, Kwon P and Moss WJ. Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: case report and review. Clin Pediatr (Phila). 2005; 44:443-450.
26. van Oosten M, Schafer T, Gazendam JA, Ohlsen K, Tsompanidou E, de Goffau MC, Harmsen HJ, Crane LM, Lim E, Francis KP, Cheung L, Olive M, Ntziachristos V, van Dijl JM and van Dam GM. Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat Commun. 2013; 4:2584.
27. Wehrl HF, Wiehr S, Divine MR, Gatidis S, Gullberg GT, Maier FC, Rolle AM, Schwenck J, Thaiss WM and Pichler BJ. Preclinical and Translational PET/MR Imaging. J Nucl Med. 2014; 55:11S-18S.
28. Santangelo PJ, Rogers KA, Zurla C, Blanchard EL, Gumber S, Strait K, Connor-Stroud F, Schuster DM, Amancha PK, Hong JJ, Byrareddy SN, Hoxie JA, Vidakovic B, Ansari AA, Hunter E and Villinger F. Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nat Methods. 2015; 12:427-432.
29. Ning X, Seo W, Lee S, Takemiya K, RafiM, Feng X, Weiss D, Wang X, Williams L, Camp VM, Eugene M, Taylor WR, Goodman M and Murthy N. PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed Engl. 2014; 53:14096-14101.
30. Mills B, Awais RO, Luckett J, Turton D, Williams P, Perkins AC and Hill PJ. [(18)F]FDG-6-P as a novel in vivo tool for imaging staphylococcal infections. EJNMMI Res. 2015; 5:13.
31. Rolle AM, Hasenberg M, Thornton CR, Solouk-Saran D, Mann L, Weski J, Maurer A, Fischer E, Spycher PR, Schibli R, Boschetti F, Stegemann-Koniszewski S, Bruder D, Severin GW, Autenrieth SE, Krappmann S, et al. ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo. Proc Natl Acad Sci U S A. 2016.
32. Verel I, Visser GW and van Dongen GA. The promise of immuno-PET in radioimmunotherapy. J Nucl Med. 2005; 46 Suppl 1:164S-171S.
33. Wu AM and Olafsen T. Antibodies for molecular imaging of cancer. Cancer J. 2008; 14:191-197.
34. Holliger P and Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol. 2005; 23:1126-1136.
35. Kenanova VE, Olafsen T, Salazar FB, Williams LE, Knowles S and Wu AM. Tuning the serum persistence of human serum albumin domain III:diabody fusion proteins. Protein Eng Des Sel. 2010; 23:789-798.
36. Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res. 1990; 50:814s-819s.
37. Holliger P, Prospero T and Winter G. "Diabodies": small bivalent and bispecific antibody fragments. Proc Natl Acad Sci U S A. 1993; 90:6444-6448.
38. Tsai SW, Li L, Williams LE, Anderson AL, Raubitschek AA and Shively JE. Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments. Bioconjug Chem. 2001; 12:264-270.
39. Behr TM, Sharkey RM, Juweid ME, Blumenthal RD, Dunn RM, Griffiths GL, Bair HJ, Wolf FG, Becker WS and Goldenberg DM. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res. 1995; 55:3825-3834.
40. Dearling JL, Paterson BM, Akurathi V, Betanzos-Lara S, Treves ST, Voss SD, White JM, Huston JS, Smith SV, Donnelly PS and Packard AB. The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution. Bioconjug Chem. 2015; 26:707-717.
41. Miao Z, Ren G, Liu H, Jiang L and Cheng Z. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. Bioconjug Chem. 2010; 21:947-954.
42. Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, Hudson C, Leyton J, Burnet J, Oyen WJ, Blower PJ, Mather SJ, Boerman OC and Sosabowski JK. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In. Mol Pharm. 2014; 11:3930-3937.
43. Hamacher K, Coenen HH and Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986; 27:235-238.
44. Grosskinsky U, Schutz M, Fritz M, Schmid Y, Lamparter MC, Szczesny P, Lupas AN, Autenrieth IB and Linke D. A conserved glycine residue of trimeric autotransporter domains plays a key role in Yersinia adhesin A autotransport. J Bacteriol. 2007; 189:9011-9019.
45. Alt K, Wiehr S, Ehrlichmann W, Reischl G, Wolf P, Pichler BJ, Elsasser-Beile U and Buhler P. High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native celladherent PSMA. Prostate. 2010; 70:1413-1421.
46. Ahrens ET and Bulte JW. Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol. 2013; 13:755-763.